Evidence map›Paper›PMID 33803107›Full record

ArticleMolecules (Basel, Switzerland)2021

Dual Effect of Taxifolin on ZEB2 Cancer Signaling in HepG2 Cells.

Zdenek Dostal, Martin Sebera, Josef Srovnal, Katerina Staffova, Martin Modriansky

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Determination ofTechnology in cancer research & treatment
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Zdenek DostalDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, 77515 Olomouc, Czech Republic.
Martin SeberaFaculty of Sport Studies, Masaryk University, 60177 Brno, Czech Republic.ORCID 0000-0003-3750-1549
Josef SrovnalInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, 77515 Olomouc, Czech Republic.ORCID 0000-0003-1063-8334
Katerina StaffovaInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, 77515 Olomouc, Czech Republic.
Martin ModrianskyDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, 77515 Olomouc, Czech Republic.ORCID 0000-0001-7692-0338
Institute of Molecular and Translational Medicine · CZPalacký University Olomouc · CZMasaryk University · CZ

Funding

Ministry of Education of the Czech Republic RVO 61989592Palacký University IGA_LF_2020_022
6 · The paper itself

Abstract

Polyphenols, secondary metabolites of plants, exhibit different anti-cancer and cytoprotective properties such as anti-radical, anti-angiogenic, anti-inflammation, or cardioprotective. Some of these activities could be linked to modulation of miRNAs expression. MiRNAs play an important role in posttranscriptional regulation of their target genes that could be important within cell signalling or preservation of cell homeostasis, e.g., cell survival/apoptosis. We evaluated the influence of a non-toxic concentration of taxifolin and quercetin on the expression of majority human miRNAs via Affymetrix GeneChip™ miRNA 3.0 Array. For the evaluation we used two cell models corresponding to liver tissue, Hep G2 and primary human hepatocytes. The array analysis identified four miRNAs, miR-153, miR-204, miR-211, and miR-377-3p, with reduced expression after taxifolin treatment. All of these miRNAs are linked to modulation of ZEB2 expression in various models. Indeed, ZEB2 protein displayed upregulation after taxifolin treatment in a dose dependent manner. However, the modulation did not lead to epithelial mesenchymal transition. Our data show that taxifolin inhibits Akt phosphorylation, thereby diminishing ZEB2 signalling that could trigger carcinogenesis. We conclude that biological activity of taxifolin may have ambiguous or even contradictory outcomes because of non-specific effect on the cell.

Indexed as

ApoptosisCell MovementCell ProliferationEpithelial-Mesenchymal TransitionGene ExpressionGene Expression Regulation, NeoplasticHepatocytesHep G2 CellsHumansMicroRNAsPolyphenolsPrimary Cell CultureQuercetinSignal TransductionTranscriptomeZinc Finger E-box Binding Homeobox 2MicroRNAsMIRN153 microRNA, humanMIRN204 microRNA, humanMIRN211 microRNA, humanMIRN377 microRNA, humanPolyphenolsQuercetintaxifolinZEB2 protein, humanZinc Finger E-box Binding Homeobox 2Affymetrix GeneChip™ miRNA 3.0 ArrayHep G2 cellspolyphenolsprimary cultures of human hepatocytesZEB2

Identifiers

PMID33803107
PMCPMC7963166
OpenAlexW3134900977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.